October 20, 2020
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Brickell Biotech, Inc.
Registration Statement on Form S-1
File Number 333-249441
Ladies and Gentlemen:
Brickell Biotech, Inc. (the “Company”) hereby requests that the effectiveness of the above-referenced registration statement be accelerated so that it will become effective at 4:00 p.m. Eastern time on October 22, 2020, or as soon thereafter as practicable.
Please telephone the undersigned (305-582-4657) or Jonathan R. Zimmerman of Faegre Drinker Biddle & Reath LLP (612-766-8419) if you have any questions with respect to the foregoing.
Very truly yours,
BRICKELL BIOTECH, INC.
| ||By:||/s/ Andrew Sklawer|| |
| || ||Name: Andrew Sklawer|| |
| || ||Title: Chief Operating Officer|